8 Most Oversold Healthcare Stocks to Invest In
Calling it a textbook classic move, he stated that we had a geopolitical shock and markets sold off hard before snapping right back up, making it the classic V shape.
Caris Life Sciences Inc. (CAI)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 610,233 | $10,910,966 | +13% | 0.31% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.09 | 4,184 | $100,792.56 | 9,184 | 2025-11-07 | Filing | |
| $23.85 | 400 | $9,540.00 | 460,777 | 2025-11-07 | Filing | |
| $21.00 | 7,500 | $157,500.00 | 123,591 | 2025-06-20 | Filing | |
| $21.00 | 30,000 | $630,000.00 | 162,428 | 2025-06-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.16 | 1,400 | $38,017.56 | 99,571 | 2025-12-11 | Filing | |
| $26.56 | 60,850 | $1,616,443.74 | 100,971 | 2025-12-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 32,500 | $581,100 | 0.01% | |
| 2. | 13,500 | $241,380 | 0% | |
| 3. | 10,715 | $209,050 | 0.01% | |
| 4. | 6,337 | $113,306 | 0% | |
| 5. | 1,753 | $31,344 | 0% |
News See All
10 Best NASDAQ Stocks Under $30 to Buy
On March 9, Allan Small, Senior Investment Advisor for Allan Small Financial Group at iA Private Wealth, appeared on BNN Bloomberg to discuss the extreme volatility of oil prices and the resulting investment...
Caris Life Sciences, Inc. (NASDAQ:CAI) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the Caris Life Sciences Q4 2025 Earnings Call. My name is Dana, and I will be your coordinator today.
Caris Life Sciences (CAI) Adds New AI-powered Breast Cancer Signature to its Report
Caris Life Sciences, Inc. (NASDAQ:CAI) is one of the Best All-Time Low Stocks to Invest In Now. On February 24, Caris Life Sciences, Inc.
12 Best All-Time Low Stocks to Invest In Now
On February 24, Paul Christopher, Wells Fargo's head of global market strategy, appeared on a CNBC television interview to discuss market outlooks.
Baird Initiates Coverage of Caris Life Sciences, Inc. (CAI) with an Outperform Rating
On February 17, 2026, Baird initiated coverage of Caris Life Sciences, Inc. (NASDAQ:CAI) with an Outperform rating and a $26 price target. Baird described Caris Life Sciences, Inc.
11 Newly-Listed NASDAQ Stocks to Buy Now
IPO activity is starting to recover after a quiet stretch.
Cannaccord Genuity Asserts Hold Stance on Caris Life Sciences, Inc. (CAI) On Oncology Pipeline Development
Caris Life Sciences Inc. (NASDAQ:CAI) is one of the best biotech stocks to buy according to Wall Street analysts.
15 Best Biotech Stocks to Buy According to Wall Street Analysts
The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain for the S&P 500 over the same period.
Caris Life Sciences, Inc. (NASDAQ:CAI) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the Caris Life Sciences Third Quarter 2025 Earnings Call. My name is Shannon, and I will be your coordinator today. [Operator Instructions].
Hedge Fund Resource Center